Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia

Clinical Endocrinology

Volumn 65, Issue 1, 2006, Pages 45-50

  Merza, Z ^a   Rostami Hodjegan, A ^a   Memmott, A ^b   Doane, A ^a   Ibbotson, V ^a   Newell Price, J ^a   Tucker, G T ^a   Ross, R J ^a,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; HYDROXYPROGESTERONE;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CASE REPORT; CHEMOLUMINESCENCE; CIRCADIAN RHYTHM; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOASSAY; MALE; PILOT STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUSTAINED RELEASE PREPARATION;

17-ALPHA-HYDROXYPROGESTERONE; ADMINISTRATION, ORAL; ADRENAL HYPERPLASIA, CONGENITAL; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ADULT; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; COMPUTER SIMULATION; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED;

EID: 33745202812     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02544.x     Document Type: Article

References (19)

1. Crown A. Lightman S. ( 2005) Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clinical Endocrinology, 63, 483 492.
2. Krieger D.T. Allen W. Rizzo F. Krieger H.P. ( 1971) Characterization of the normal temporal pattern of plasma corticosteroid levels. Journal of Clinical Endocrinology and Metabolism, 32, 266 284.
3. Born J. Hansen K. Marshall L. Molle M. Fehm H.L. ( 1999) Timing the end of nocturnal sleep. Nature, 397, 29 30.
4. Ten S. New M. Maclaren N. ( 2001) Addison's disease. Journal of Clinical Endocrinology and Metabolism, 86, 2909 2922.
5. Arlt W. Allolio B. ( 2003) Adrenal insufficiency. Lancet, 361, 1881 1893.
6. Joint LWPES/ESPE CAH Working Group ( 2002) Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Journal of Clinical Endocrinology and Metabolism, 87, 4048 4053.
7. Lovas K. Loge J.H. Husebye E.S. ( 2002) Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology, 56, 581 588.
8. Riedel M. Wiese A. Schurmeyer T.H. Brabant G. ( 1993) Quality of life in patients with Addison's disease: effects of different cortisol replacement modes. Experimental and Clinical Endocrinology, 101, 106 111.
9. Arlt W. ( 2002) Quality of life in Addison's disease: the case for DHEA replacement. Clinical Endocrinology, 56, 573 574.
10. Howlett T.A. ( 1997) An assessment of optimal hydrocortisone replacement therapy. Clinical Endocrinology, 46, 263 268.
11. Mah P.M. Jenkins R.C. Rostami-Hodjegan A. Newell-Price J. Doane A. Ibbotson V. Tucker G.T. Ross R.J. ( 2004) Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clinical Endocrinology, 61, 367 375.
12. Charmandari E. Matthews D.R. Johnston A. Brook C.G. Hindmarsh P.C. ( 2001) Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? Journal of Clinical Endocrinology and Metabolism, 86, 4679 4685.
13. Moeller H. ( 1985) Chronopharmacology of hydrocortisone and 9 alpha-fluorhydrocortisone in the treatment for congenital adrenal hyperplasia. European Journal of Pediatrics, 144, 370 373.
14. Ross R.J. ( 2000) UK audit of adult congenital adrenal hyperplasia care. Journal of Endocrinology, 164, Abstract: S38.
15. Cutler G.B. ( 1996) Treatment of congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 81, 3185 3186.
16. Chakraborty A. Krzyzanski W. Jusko W.J. ( 1999) Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods. Journal of Pharmacokinetics and Biopharmaceutics, 27, 23 43.
17. Dunlap J.C. ( 1999) Molecular bases for circadian clocks. Cell, 96, 271 290.
18. Arlt W. Allolio B. ( 2003) DHEA replacement in adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism, 88, 4001 4002.
19. Kehlet H. Binder C. Blichert-Toft M. ( 1976) Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation. Clinical Endocrinology, 5, 37 41.